Normal view MARC view ISBD view

[The nucleotide composition and oligonucleotides of the pyrimidyl-ribonuclease digest of valine-specific transfer RNA]. [electronic resource]

By:

Krutilina, A I

Contributor(s):

Producer: 19670710Description: 1225-35 p. digitalISSN:

0320-9725

Subject(s):

In: Biokhimiia (Moscow, Russia) vol. 30

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

21 Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brain.
by Chen, L
22 Is ischemic cerebrovascular disease a risk factor for dementia in patients with Parkinson's disease?
by Papapetropoulos, S
23 Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain.
by Hurley, M J
24 The effect of altered 5-hydroxytryptamine levels on beta-endorphin content in rat brain.
by Soliman, K F
25 Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease.
by Ferrari-DiLeo, G
26 Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex.
by Mash, D C
27 Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease.
by Mufson, E J
28 The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain.
by Baumann, M H
29 Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
by Flynn, D D
30 Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor.
by Rossi, M A
31 Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
by Flynn, D D
32 Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.
by Mash, D C
33 Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities.
by Segal, D M
34 Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
by Mash, D C
35 Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
by Papapetropoulos, S
36 Characterization of kappa1-opioid receptor binding in human insular cortex.
by Izenwasser, S
37 Circadian variations in radioligand binding to muscarine receptors in rat brain dependent upon endogenous agonist occupation.
by Mash, D C
38 Dopamine transporter mRNA in autopsy studies of chronic cocaine users.
by Chen, L
39 Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
by Ferrari-Dileo, G
40 Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.
by Staley, J K